US-based chipmaker Nvidia has entered into a partnership with GlaxoSmithKline (GSK) and its artificial intelligence (AI) group for the discovery of drugs and vaccines.
The Scripps Research Translational Institute is partnering with graphics firm NVIDIA to develop AI and deep learning best practices, tools and infrastructure to develop AI applications using genomic and digital health sensor data